-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Oyster Point Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q3 2022.
- Oyster Point Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$36.7M, a 108% decline year-over-year.
- Oyster Point Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$177M, a 119% decline year-over-year.
- Oyster Point Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$101M, a 42.7% decline from 2020.
- Oyster Point Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$70.5M, a 54.3% decline from 2019.
- Oyster Point Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2019 was -$45.7M, a 177% decline from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)